Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa

Summary
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients with hidradenitis...
Description from Medpagetoday.
Who is covering this
-
Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients with hidradenitis...
Comments
Comments need JavaScript.